Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Trabectedin in Localized Myxoid/Round Cell Liposarcoma
NCT00579501Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2007
- Primary completion
- Jan 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of trabectedin in myxoid liposarcoma (MLPS), myxoid/round cell liposarcoma (MRCLS), sponsored by Johnson & Johnson. Started Apr 2007; status: completed.
02
Drugs
trabectedin
03
Conditions
myxoid liposarcoma (MLPS)myxoid/round cell liposarcoma (MRCLS)
Beyond the preview
Go deeper on NCT00579501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00579501.